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ABSTRACT 
Background: To analyze the academic characteristics, career trajectory, scholarly publications, and demographic background of 
the 100 most-cited authors in ophthalmic literature. 
Methods: In this observational cross-sectional study, a database containing every ophthalmology journal article from 1967 to 2018 
was built using Scopus journal article information. The 100 authors with the most citations were identified, along with a control 
group of authors with at least five publications. Information about each author, such as gender, institution, and educational 
degrees were found from online web searches. Intra- and inter-group analyses were performed to identify correlations that may 
lead to having a high level of impact in ophthalmology literature. 
Results: Of the 100 most-cited ophthalmologists, 56 practice in the United States (US) and only 12 are female. In an odds ratio 
(OR) analysis, highly-cited researchers more often lived in the US (OR, 2.97; P < 0.001), were male (OR, 2.4; P = 0.02), and graduated 
from an elite medical school (OR, 3.89; P = 0.02) and/or residency (OR, 3.67; P = 0.02), but were not from an undergraduate 
institution (P = 0.75). There was no difference in citation numbers between different ophthalmology subspecialties (P = 0.22) or 
advanced degrees (PhD, MPH in addition to MD). Women among the top-100-cited authors were more likely to author high impact 
journal articles (P < 0.05). 
Conclusions: Among highly-cited ophthalmologists, practicing in the US and attending a top medical school or residency program 
may provide training for a successful research career in ophthalmology. Additionally, top female ophthalmologists participate in 
more influential research. 
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INTRODUCTION 
The impact of a career in ophthalmic research is based on 
a series of decisions. These include selecting a medical 
school and residency program, choosing between 
academic and private practice, whether to pursue 
fellowship training and/or additional advanced degrees 
such as a Master of Public Health (MPH), Master of 
Business Administration (MBA), or Doctor of Philosophy 
(PhD). These options can be instrumental in facilitating a 
fruitful academic career [1-4]. Previous studies have 
described the characteristics of American ophthalmology 
residency program directors [1], department chairs [2], 
and clinician-scientists receiving National Institute of 
Health (NIH) grants [3]. Gershoni et al. investigated the 
impact of subspecialty choice on research productivity, 
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ABSTRACT
Background: Cataract surg ry in patients with diabetes is indicated either to improve visual acuity or to 
allow assessment and treatment of fundus changes. We aimed to document the effects of phacoemulsification 
on the corneal endothelium in patients with or without diabetes.
Methods: This comparative, prospective, non-randomized controlled interventional study was conducted 
in patients with visually significant immature senile cataracts in the ophthalmology department at Sohag 
Univer ity Hospital between January 2018 and December 2020. The following data were recorded: corrected 
distance vis al a uity, kerat metry readings, refraction, slit lamp examination results, and biometry data. 
Changes in corneal parameters were documented preoperatively and at 1, 3, and 6 months postoperatively 
using specular microscopy.
Results: Sixty-four eyes of 64 patients with visually significant senile cataracts were included (32 eyes in the 
diabetic group and 32 eyes in the non-diabetic control group). We found greater mean endothelial cell loss in 
the non-diabetic group (179 cells/mm2; 6.4%) than in the diabetic group (134 cells/mm2; 4.8%) at 3 months 
postoperativ ly, yet the difference was not significant. The difference could be explained by the higher mean 
cumulative dissipated energy (CDE) used in the non-diabetic group (5.37 J) than in the diabetic group (4.68 
J), although the difference wa  also not significant. Moreover, we found significantly higher coefficient of 
variation (CV) in the non-diabetic group than in the diabetic group at 1, 3, and 6 months postoperatively (P 
= 0.03, P = 0.02, and P = 0.008, respectively).
Conclusions: Endothelial cell density was directly related to the CDE of phacoemulsification and not to 
diabetes. CV was significantly higher in the non-diabetic group than in the diabetic group. Future studies 
with a larger sample size, longer follow-up, and more diabetic subgroups with different levels of glycemic 
control are warranted to verify our conclusions.
KEY WORDS  
phacoemulsification, intraocular, cumulative dissipated energy, cataract surgery, diabetes mellitus, corneal 
endothelium, diabetic, non-diabetic, specular microscopy, endothelial cell density, coefficient of variation, 
central corneal thickness
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INTRODUCTION
Cataract surgery with phacoemulsification is one of the most common surgical procedures performed 
nowadays. Compared to non-diabetic patients, patients with diabetes have an increased risk of developing 
cataracts [1, 2]. Cataract surgery in patients with diabetes is indicated not only to improve visual acuity but 
also to allow assessment and treatment of fundus changes [3]. 
Good vision after phacoemulsification requires a clear cornea. The corneal endothelium plays an important 
role in keeping the cornea clear via the endothelial pump mechanism. However, phacoemulsification 
may damage the corneal endothelium [4]. Morphologically abnormal endothelium has been observed in 
patients with diabetes. Patients with diabetes undergoing phacoemulsification are vulnerable to greater 
endothelial damage, and their visual acuity may drop despite good glycemic control [5]. Endothelial cell 
density (ECD) is lower in diabetic patients than in non-diabetic patients, and is inversely correlated with 
the duration of diabetes and hemoglobin A1c (HbA1c) levels [6, 7].
One study reported a greater loss in ECD following phacoemulsification in diabetic versus non-diabetic 
patients [8]. In contrast, endothelial cell loss following phacoemulsification is similar in diabetic and non-
diabetic patients. However, a significant increase in the coefficient of variation (CV) and central corneal 
thickness (CCT), as well as a significant decrease in hexagonality have been documented in diabetic 
patients after phacoemulsification [9]. Due to the lack of consensus in the literature concerning the impact 
of phacoemulsification on corneal parameters in patients with diabetes, further studies are needed.
To document the effects of phacoemulsification and its potential hazards on the corneal endothelium in 
diabetic versus non-diabetic patients, we conducted a comparative, prospective study.
METHODS
This comparative, prospective, non-randomized controlled interventional study was approved by the 
Institutional Review Board (IRB) of the Faculty of Medicine, Sohag University, Egypt. In addition, it 
was registered at the Pan African Clinical Trial Registry (PACTR201804003056259) and adhered to 
the tenets of the Declaration of Helsinki. All surgeries were performed by a single surgeon (A.M.) at the 
ophthalmology department of Sohag University Hospital between January 2018 and December 2020.
The study included 64 eyes of 64 patients with visually significant senile cataracts. The study eyes were 
divided into two groups: Group A (control, non-diabetic group), comprising 32 eyes of 32 patients who 
were non-diabetic and had visually significant cataracts; and Group B (experimental, diabetic group), 
comprising 32 eyes of 32 patients with type 2 diabetes mellitus (T2 DM), no diabetic retinopathy, and 
visually significant cataracts. The nature of both diseases (senile cataracts and diabetes mellitus), treatment 
modality options, and potential intraoperative and postoperative consequences were explained carefully 
to all patients, who signed an informed consent form prior to surgery. All participants underwent a 
complete ophthalmic examination, and preoperative and postoperative measurements of ECD, CV, CCT, 
hexagonality, and minimal, maximal, and average cell sizes at 1, 3, and 6 months postoperatively.
The inclusion criteria for Group A were as follows: senile nuclear cataracts of nuclear grades NI and 
NII according to the Lens Opacities Classification System (LOCUS) III [10], no diabetes, normal fundus 
examinations, and intraocular pressure (IOP) within the normal range. The inclusion criteria for Group 
B were as follows: senile nuclear cataracts of nuclear grades NI and NII according to LOCUS III, age 50 
to 70 years, well-documented T2 DM with a duration of ≥ 5 years, good glycemic control (glycosylated 
HbA1c < 7%) with oral hypoglycemic drugs, normal fundus examinations, and IOP within the normal 
range. We excluded patients with corneal pathology or low endothelial cell count (< 2000 cells/mm2), poor 
pupillary dilatation, pseudo-exfoliation syndrome, high IOP, glaucomatous optic neuropathy, a previous 
history of ocular trauma or uveitis, previous eye surgery, current or previous macular edema, maculopathy 
or retinopathy, and cataract density interfered with preoperative ocular coherence tomography (OCT) 
imaging.
Specular microscopy was performed using an SP-1P device (Topcon Medical Systems, Inc., Oakland, 
NJ, USA) to measure the following parameters: ECD, CV, CCT, hexagonality, and minimal, maximal, 
and average cell sizes. Afterwards, all patients underwent cataract surgery using a phaco machine with 
the Infiniti Vision System plus OZil coupled with IP software (Alcon Laboratories Inc., Fort Worth, TX, 
USA). To obtain adequate pupillary dilation under topical anesthesia (benoxinate hydrochloride eye 
drops 0.4%; EPICO, 10th of Ramadan City, Egypt), cyclopentolate hydrochloride 50 mg + phenylephrine 
hydrochloride 500 mg eye drops (Cyclophrine eye drops; Kahira Pharm, Cairo, Egypt) was instilled into 
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the eye every 10 min for 30 min. Subsequently, the retrobulbar block was supplemented with facial nerve 
block anesthesia using lidocaine 2% sodium hyaluronate (Xylocaine; AstraZeneca, Cambridge, UK). 
Periorbital, forehead, and cheek skin was disinfected with 10% povidone-iodine (Betadine, Antiseptic 
Solution; Nile Company for Pharmaceuticals and Chemical Industries, Cairo, Egypt) immediately before 
surgery at the side of the operation table. Furthermore, half-strength (5%) povidone-iodine was instilled 
into the surgical eye immediately before surgery, and a disposable eye drape with a fluid collection bag 
(Freedom Ophthalmic Pvt. Ltd., Tamil Nadu, India) was placed over the open eye. The eyelids were kept 
open using an eye speculum.
We intended to perform a typical tri-planar wound to promote incision self-sealing. Two paracentesis 
incisions were made using a 20-gauge MVR knife (Alcon Laboratories Inc., Fort Worth, TX, USA), 
followed by a clear corneal incision using a dual-bevel 2.2-mm angled slit knife (Intrepid ClearCut HP2; 
Alcon Laboratories, Inc., Fort Worth, TX, USA). 
Air was injected into the anterior chamber (AC) via the paracentesis incision followed by injection of 
the trypan blue ophthalmic solution (0.6 mg/mL) (Optiblu, Ophtechnics Unlimited, Haryana, India) 
to stain the anterior capsule. The residual dye was washed out by injecting compound sodium lactate 
solution (Ringer’s lactate solution for intravenous infusion; Allmed Middle East Co., Giza, Egypt) into 
the AC. Subsequently, AC was formed by injecting a cohesive OVD (1.4% sodium hyaluronate ophthalmic 
solution; Optiflex, Moss Vision Inc. Ltd., London, UK). To perform continuous curvilinear capsulorhexis, 
an angular tab in the anterior capsule was made, then pulled in a curvilinear fashion, and the continuous 
tear proceeded clockwise by grasping the tearing edge with the capsulorhexis forceps (to control the 
vector of the tear); finally, a regular circular opening was formed. The next steps were cortical cleaving 
hydrodissection and OVD-assisted hydrodissection.
We planned to fix the intraoperative phacoemulsification settings. Phaco 1 parameters (sculpting) were 
set as follows: linear torsional amplitude, 100; phaco power, 0%; vacuum, 95 mmHg; bottle height, 98 cm; 
and aspiration flow rate, 23 mL/min. Phaco 2 parameters were set as follows: linear torsional amplitude, 
95; phaco power, 0%; vacuum, 400 mmHg; bottle height, 95 cm; aspiration flow rate, 25 mL/min; dynamic 
rise, -2; and intelligent phaco, on. The epinucleus parameters were set as follows: linear torsional amplitude, 
25; phaco power, 0%; vacuum, 330 mmHg; bottle height, 95 cm; aspiration flow rate, 24 mL/min; dynamic 
rise, 0; and intelligent-phaco, off. The cortex parameters were set as follows: vacuum, 380 mmHg; and 
aspiration flow rate, 30 mL/min. 
Phacoemulsification was performed using the stop-and-chop technique. Automated irrigation aspiration 
of the cortical matter was then performed. Methyl cellulose was injected into the capsular bag, and AC 
was formed immediately before implantation of a foldable single-piece hydrophilic silicon intraocular lens 
with aspheric optics (UFold; Action Medical Pvt. Ltd., Maharashtra, India). The incisions were closed by 
hydration using Ringer’s lactate solution. Finally, moxifloxacin ophthalmic solution 0.5% (VIGAMOX; 
Alcon Laboratories, Inc., Fort Worth, TX) and prednisolone acetate 1% ophthalmic suspension (Econopred 
Plus; Alcon Laboratories Inc., Fort Worth, TX, USA) were instilled, followed by eye patching. Finally, the 
cumulative dissipated energy (CDE) used in each case was recorded.
Data were analyzed using Stata (version 14.2; StataCorp). Quantitative data are represented as the mean 
and standard deviation (SD) and/or the median and range. Student’s t-test was used to compare the means 
of two groups, and analysis of variance (ANOVA) was used for comparison of three or more means. For 
non-normally distributed data, the Mann–Whitney test was used to compare the means of two groups, 
and the Kruskal–Wallis test was used to compare three or more means. Qualitative data are presented as 
numbers and percentages and compared using either the chi-square test or Fisher’s exact test. Comparison 
between preoperative and postoperative follow-up data at 1, 3, and 6 months was performed using repeated 
measures ANOVA. Mauchly’s test of sphericity was used to examine sphericity. Bonferroni’s post-hoc test 
was used to examine the differences at each time point. Spearman’s rank order correlation coefficient was 
used because the data were not normally distributed. Statistical significance was set at P < 0.05.
RESULTS
The study included 64 eyes of 64 patients (one eye per patient), 33 (51.6%) of whom were men. The mean 
age ± SD was 59.59 ± 5.20 years in Group A and 58.13 ± 3.88 years in Group B. The preoperative baseline 
values were comparable between the two groups (Table 1).
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Table 1. Characteristics of the study participants
Variable Group A
(n = 32 eyes)
Group B
(n = 32 eyes)
P- value 
Age, years 


















Abbreviations: n, number; %, percentage; NI, nuclear senile cataract grade NI hardness; NII, nuclear senile cataract grade NII hardness; SD, 
standard deviation. Note: Group A, non-diabetic patients; Group B, diabetic patients.
Table 2. Comparative analysis of central corneal thickness and endothelial cell parameters using specular microscopy
Variable Group A
Mean ± SD, Median (Range)
Group B







6 months postop - preop
508.78 ± 24.78, 507 (453 to 555)
511.94 ± 27.46, 510.5 (457 to 565)
510.94 ± 26.59, 506 (460 to 563)
509 ± 26.56, 509 (460 to 567)
0.22 ± 17.81, 0.5 (-52 to 39)
513.77 ± 29.68, 513 (438 to 554)
517.53 ± 28.22, 519.5 (456 to 551)
516.78 ± 27.04, 521 (454 to 553)
515.22 ± 30.36, 511.5 (451 to 569)











6 months postop - preop
2799 ± 349.69, 2799 (2137 to 3503)
2578.75 ± 360.39, 2571 (1816 to 3374)
2620.75 ± 360.23, 2660 (1850 to 3464)
2654.19 ± 351.80, 2696.5 (1851 to 3476)
-144.81 ± 144.58, -85 (-666 to [-7])
2755.38 ± 333.27, 2737 (2207 to 3398)
2554.38 ± 340.49, 2591 (2007 to 3155)
2621.93 ± 318.54, 2635.5 (2203 to 3210)
2648.63 ± 331.49, 2650 (2200 to 3285)











6 months postop - preop
36.16 ± 4.21, 36 (30 to 44)
38.72 ± 4.62, 38.5 (28 to 48)
38.72 ± 4.62, 38.5 (28 to 48)
39.38 ± 4.36, 40.5 (31 to 47)
3.22 ± 3.95, 2 (-3 to 13)
35.38 ± 4.56, 35.5 (26 to 41)
35.84 ± 5.44, 38 (24 to 42)
35.78 ± 5.42, 38 (24 to 42)
36.09 ± 5.16, 37 (24 to 47)











6 months postop - preop
48.16 ± 6.93, 48 (30 to 67)
42.84 ± 9.59, 43.5 (19 to 58)
41.69 ± 10.11, 44 (18 to 62)
42.78 ± 9.10, 42 (26 to 66)
-5.38 ± 10.2, -7 (-22 to 20)
51.5 ± 8.08, 52.5 (37 to 65)
47.25 ± 10.36, 49 (21 to 64)
46.44 ± 8.77, 47 (32 to 63)
44.09 ± 12.67, 44 (15 to 65)











6 months postop - preop
122.66 ± 12.23, 118 (103 to 148)
130.72 ± 19.64, 126 (111 to 190)
126.88 ± 17.25, 123.5 (109 to 180)
124.78 ± 17.99, 117 (109 to 183)
2.13 ± 19.73, -1 (-0.25 to 62)
125.63 ± 11.84, 124.5 (109 to 146)
150.96 ± 44.20, 131 (115 to 272)
133.06 ± 21.85, 127.5 (103 to 184)
135.16 ± 22.26, 134 (111 to 200)











6 months postop - preop
798.06 ± 147.35, 795 (554 to 1083)
864.81 ± 195.27, 834 (554 to 1553)
821.19 ± 173.41, 778 (566 to 1565)
827.91 ± 187.24, 768.5 (528 to 1549)
29.84 ± 136.333, 32 (-190 to 466)
821 ± 111.30, 797.5 (679 to 1050)
825.94 ± 143.22, 822.5 (590 to 1105)
819.09 ± 130.14, 793.5 (575 to 1084)
789.19 ± 81.74, 778 (668 to 939)











6 months postop - preop
362.72 ± 42, 357.5 (285 to 468)
394.44 ± 58.48, 389 (296 to 551)
385.5 ± 59.96, 376 (285 to 548)
380.97 ± 57.72, 369 (288 to 549)
18.25 ± 28.39, 10.5 (-27 to 125)
368 ± 44.13, 365 (294 to 453)
394.47 ± 57.99, 385 (300 to 498)
380.66 ± 44.73, 378 (289 to 454)
378.41 ± 48.27, 375 (276 to 459)






Abbreviations: preop, preoperative; postop, postoperative; µm, micrometer; cells/mm2, number of cells per square millimeter; %, percentage; 
µm2, square micrometers; CCT, central corneal thickness; ECD, endothelial cell density; CV, coefficient of variation. P-values were calculated 
using either Student’s t-test for normally distributed data or the Mann–Whitney test for non-normally distributed data. P-value < 0.05 is shown 
in bold. Note: Group A, non-diabetic patients; Group B, diabetic patients.
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Table 3. Comparative analysis of phaco parameters
Variable Group A
Mean ± SD, Median (Range)
Group B
Mean ± SD, Median (Range)
P- value 
CDE ( J) 5.37 ± 3.54, 4.18 (0.86 to 16.85) 4.68 ± 2.99, 4.66 (0.76 to 9.86) 0.66
US total (torsional) time (s) 27.79 ± 16.72, 22.25 (2.7 to 75.7) 25.43 ± 12.81, 27.35 (7.2 to 45.7) 0.95
Estimated fluid used (cc) 96.44 ± 27.44, 92.5 (37 to 181) 110.69 ± 33.82, 107 (65 to 181) 0.15
Abbreviations: SD, standard deviation; CDE, cumulative dissipated energy (expressed in joules); J, joules; US, ultrasound; s, seconds; cc, cubic 
centimeter; r, correlation coefficient. Note: Group A, non-diabetic patients; Group B, diabetic patients. Spearman’s rank order correlation 
coefficient was used because the data were not normally distributed.
Table 4. Comparative analysis of correlation coefficient (r)
Variables Group A Group B
r P- value r P- value
CDE ( J) & ECD (cells/mm2) -0.49 0.01 -0.42 0.02
CDE ( J) & CCT (µm) 0.14 0.44 0.43 0.01
US total (torsional) time (s) & ECD (cells/mm2) -0.07 0.70 -0.12 0.50
US total (torsional) time (s) & CCT (µm) 0.13 0.48 -0.20 0.27
Abbreviations: CDE, cumulative dissipated energy (expressed in joules); J, joules; ECD, endothelial cell density; cells/mm2, number of cells 
per square millimeter; CCT, central corneal thickness; µm, micrometers; US, ultrasound; s, seconds; Group A, non-diabetic patients; Group 
B, diabetic patients. P-value < 0.05 is shown in bold. Note: Spearman’s rank order correlation coefficient was used because the data were not 
normally distributed.
Table 2 shows a comparative analysis of CCT and endothelial cell parameters measured using specular 
microscopy in Group A versus Group B. We found no statistically significant differences between the two groups 
in the preoperative and postoperative mean values of any parameter, except significantly higher mean CV and 
smaller minimal cell size in non-diabetic compared with diabetic patients (P = 0.008 and P = 0.04 at 6 months 
postoperatively, respectively). In follow-up visits, non-diabetic patients had significantly higher CV values at 1, 
3, and 6 months postoperatively than diabetic patients (P = 0.03, P = 0.02, and P = 0.008, respectively). Table 3 
shows that phaco parameters were comparable between the two groups.
Table 4 shows the correlation coefficient (r) between the CDE, ECD, CCT, and ultrasound (US) total 
(torsional) time. We found a low negative linear relationship between CDE and ECD: as CDE increased, 
ECD decreased in both non-diabetic and diabetic patients (r = -0.49 and r = -0.42 with P = 0.01 and P = 0.02, 
respectively). We also found a mild positive linear relationship between CDE and CCT: as CDE increased, CCT 
also increased in diabetic patients (r = 0.43, P = 0.01).
DISCUSSION
This study included 64 eyes of 64 patients (32 diabetic and 32 non-diabetic patients) who underwent 
phacoemulsification and posterior chamber IOL implantation to treat visually significant nuclear senile cataracts. 
Sahu et al. [11] reported the results of phacoemulsification in 120 eyes of 120 patients (60 with diabetes and 60 
without diabetes). Similar to our study, they included subjects with T2 DM, ages 50 to 70, and with a HbA1c 
level < 7%. However, their specular microscopy outcomes differed from those of the current study. At the 
3-month postoperative visit, they documented a mean endothelial cell loss of 121 cells/mm2 (4.52%) and 157 
cells/mm2 (5.95%) in the non-diabetic group versus the diabetic group (P = 0.008). In contrast, our study found 
greater mean endothelial cell loss in non-diabetic patients (179 cells/mm2; 6.4%) than in diabetic patients (134 
cells/mm2, 4.8%), although this difference was not significant. This difference between the two studies could 
be explained on the basis of the mean CDE used in each group. In the study by Sahu et al. [11], the mean CDE 
of non-diabetic patients (17.95 J) was lower than that of diabetic patients (18.97 J), but the difference was not 
significant. On the contrary, we used greater mean CDE in the non-diabetic group (5.37 J) than in the diabetic 
group (4.68 J), yet again with no significant difference. Furthermore, the overall mean CDE was greater in both 
groups than in the current study, because they performed surgery for all grades of nuclear cataracts except grade 
4, while we included only cataracts with grade NI and NII.
In addition, Sahu et al. [11] found significantly higher 3-month postoperative CV values (39.08% versus 36.20%, 
respectively) and greater postoperative CV differences (4.52% versus 3.16%, respectively) in non-diabetic than 
in diabetic patients. Similarly, we found greater postoperative CV differences in non-diabetic patients (2.56%) 
than in diabetic patients (0.4%); this difference remained significant until 6 months postoperatively (3.22% 
versus 0.72%, respectively). The higher CV in these two studies may indicate better cell response to healing, 
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repair, and restoring of endothelial cell function in non-diabetic versus diabetic patients. Furthermore, similar 
to our study, Sahu et al. [11] found lower postoperative mean hexagonality in both non-diabetic and diabetic 
patients; however, these postoperative differences were not significant. 
Similar to our preoperative findings, Beato et al. [12] reported slightly higher hexagonality in diabetics than in 
non-diabetics, yet this difference was not significant in either study. In contrast to the results obtained by Beato 
et al. [12], the mean CV on preoperative specular microscopy was slightly higher in non-diabetic patients than 
in diabetic patients in the current study, yet with no statistical significance. Budiman found significantly higher 
mean hexagonality in patients with diabetes than in those without diabetes at 1 month after phacoemulsification 
[13]. This result was in contrast with ours, in which the difference was not significant at 1, 3, or 6 months 
postoperatively between the two groups.
Abdeen et al. [14] compared the change in mean ECD at 3 months after phacoemulsification in 23 eyes of 
patients with well-controlled T2 DM versus 23 eyes of non-diabetic participants. Their inclusion criteria were 
comparable to those of the current study, except that they operated grades NII and NIII senile nuclear cataracts, 
while we included only grade NI or NII to allow better visualization and good macular OCT imaging. Similar to 
our study, the mean preoperative ECD was lower in the diabetic group than in the non-diabetic group. However, 
in contrast to our results, the mean ECD loss in the diabetic group was significantly greater than that in the 
control group at 3 months postoperatively. ECD loss was 13% in patients with diabetes versus 9% in non-diabetic 
patients. They concluded that the cornea in patients with diabetes is more vulnerable to stress and trauma, which 
leads to more ECD loss despite good glycemic control. Contrary to Abdeen et al. [14], who found significant 
endothelial cell loss in the diabetic group at 2 weeks, 1 month, and 3 months postoperatively, we found no 
significant differences between the non-diabetic and diabetic group at 1, 3, and 6 months postoperatively. A 
possible reason for the difference between the two studies could be the greater CDE with prolonged phaco time 
for the harder nuclear cataracts graded as NII and NIII in the study by Abdeen et al. [14], while we had lower 
CDE with shorter phaco time for the less hard nuclear cataracts graded as NI or NII.
Hugod et al. [5] reported postoperative results in 30 patients with diabetes and 30 non-diabetic patients 
with a 3-month follow-up. Despite significant mean ECD loss and decrease in hexagonality in diabetic patients 
compared with controls, they found no significant change in CV or CCT. This is in contrast with our result, 
which revealed significantly higher CV values at 1, 3, and 6 months postoperatively in non-diabetic versus 
diabetic patients, yet no significant difference was found in ECD and hexagonality. In addition, Storr-Paulsen et 
al. [7], who compared 107 patients with T2 DM with 128 non-diabetic patients with no history of ocular surgery, 
reported a significant increase in CCT but no significant differences in ECD, hexagonality, or variation in CV. 
Similarly, preoperative examinations in our patients revealed no significant differences in ECD, hexagonality, and 
CV between the diabetic and non-diabetic groups. In contrast, we also found no significant difference in CCT 
between the two groups preoperatively. 
Tang et al. [15] conducted a meta-analysis of 13 primary studies on corneal changes following 
phacoemulsification in diabetic versus non-diabetic patients. Their analysis of pooled data revealed a significant 
difference between the two groups in ECD and hexagonality at 1 day, 1 week, 1 month, and 3 months; in CCT 
at 1 month; and in CV at 1 week and 1 month after phacoemulsification. However, CCT at 1 day, 1 week, and 
3 months or CV at 1 day and 3 months were not significantly different between the two groups. The authors 
concluded that the cornea in patients with diabetes might be more vulnerable to stress and trauma, leading to 
more morphological abnormalities and extended recovery time [15]. Similar to our study, Misra et al. [16] and 
Wang et al. [17] have documented 6-month postoperative changes in corneal parameters; those studies had 
the longest follow-up period among the included primary studies [15]. We found no statistically significant 
differences between the groups in the preoperative and postoperative mean values of all parameters, except for 
a significantly higher mean CV at 1, 3, and 6 months as well as smaller minimal cell size at 1 and 6 months 
postoperatively in non-diabetic patients compared with diabetic patients.
Despite being a prospective study with a well-matched control group and a long postoperative follow-up, our 
study is limited by its small sample size and narrow spectrum of T2 DM in terms of glycemic control level. 
Future studies with a larger sample size, longer follow-up, and more diabetic subgroups with different levels of 
glycemic control are needed to ascertain the relationship between postoperative changes in corneal parameters 
and various levels of glycemic control. The effect of glycemic control level on corneal parameters at different 
postoperative time points in a wide range of glycemic control levels could be an important question for future 
studies. Looking for a possible correlation between phacoemulsification and corneal parameters in these diabetic 
subgroups could be another interesting subject for research.
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CONCLUSIONS
We found ECD as a sensitive parameter that was inversely related to the CDE of phacoemulsification but not 
to diabetes, as the non-diabetic group had a significant intraoperative endothelial cell loss that was associated 
with a relatively higher intraoperative CDE when compared to the diabetic group. In the non-diabetic group, the 
healthy postoperative corneal endothelium exhibited a better healing response to the surgical insult regarding 
endothelial cell polymegethism. We found significantly higher CV and smaller minimal cell size changes in the 
non-diabetic group than in the diabetic group. These outcomes may indicate the ability of the healthy corneal 
endothelium to rapidly and efficiently restore the function of the lost intraoperative endothelial cells by increasing 
cell polymegethism in non-diabetic patients.
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